Targeting cancer cells with biotin-dendrimer conjugates

European Journal of Medicinal Chemistry

Volumn 44, Issue 2, 2009, Pages 862-868

  Yang, Wenjun ^a   Cheng, Yiyun ^a   Xu, Tongwen ^b   Wang, Xueyuan ^a   Wen, Long ping ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Biotin; Cancer targeting; Conjugate; Dendrimer; Nano carrier

Indexed keywords

BIOTIN; DENDRIMER; DRUG CARRIER; FLUORESCEIN ISOTHIOCYANATE; NANOCARRIER; POLYAMIDOAMINE;

ACETYLATION; ARTICLE; BIOCOMPATIBILITY; CANCER CELL; CANCER DIAGNOSIS; CONFOCAL MICROSCOPY; CONJUGATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENERGY; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; PROTON NUCLEAR MAGNETIC RESONANCE; TARGET CELL; ULTRAVIOLET SPECTROSCOPY;

ANTINEOPLASTIC AGENTS; BIOCOMPATIBLE MATERIALS; BIOTIN; DENDRIMERS; DRUG DELIVERY SYSTEMS; FLUORESCEIN-5-ISOTHIOCYANATE; HELA CELLS; HUMANS; NEOPLASMS; POLYAMINES;

EID: 60149100143     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2008.04.021     Document Type: Article

References (43)

1. Gillies E.R., and Frechet J.M.J. Dendrimers and dendritic polymers in drug delivery. Drug Discov. Today 10 (2005) 35-43
2. Shukla R., Thomas T.P., Peters J., Kotlyar A., Myc A., and Baker J.R. Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates. Chem. Commun. (2005) 5739-5741
3. Sampathkumar S.G., and Yarema K.J. Targeting cancer cells with dendrimers. Chem. Biol. 12 (2005) 5-6
4. Khandare J., and Minko T. Polymer-drug conjugates: progress in polymeric prodrugs. Prog. Polym. Sci. 31 (2006) 359-397
5. Duncan R., and Izzo L. Dendrimer biocompatibility and toxicity. Adv. Drug Deliv. Rev. 57 (2005) 2215-2237
6. Cheng Y.Y., Xu Z.H., Ma M.L., and Xu T.W. Dendrimers as drug carriers: applications in different routes of drug administration. J. Pharm. Sci. 97 (2008) 123-143
7. Esfand R., and Tomalia D.A. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov. Today 6 (2001) 427-436
8. Tomalia D.A. Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry. Prog. Polym. Sci. 30 (2005) 294-324
9. Jansen J.F.G.A., Debrabandervandenberg E.M.M., and Meijer E.W. Encapsulation of guest molecules into a dentritic box. Science 266 (1994) 1226-1229
10. Milhem O.M., Myles C., McKeown N.B., Attwood D., and D'Emanuele A. Polyamidoamine starburst dendrimers as solubility enhancers. Int. J. Pharm. 197 (2000) 239-241
11. Bhadra D., Bhadra S., and Jain N.K. PEGlyated lysine based copolymeric dendritic micelles for solublization and delivery of artemether. J. Pharm. Pharm. Sci. 8 (2005) 467-482
12. Bhadra D., Bhadra S., Jain S.K., and Jain N.K. A PEGylated dendritic nanoparticulate carrier of fluorouracil. Int. J. Pharm. 257 (2003) 111-124
13. Asthana A., Chauhan A.S., Diwan P.V., and Jain N.K. Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled site-specific delivery of acidic anti-inflammatory active ingredient. AAPS PharmSciTech 6 (2005) E535-E542
14. Najlah M., Freeman S., Attwood D., and D'Emanuele A. Synthesis, characterization and stability of dendrimer prodrugs. Int. J. Pharm. 308 (2006) 175-182
15. Najlah M., Freeman S., Attwood D., and D'Emanuele A. In vitro evaluation of dendrimer prodrugs for oral drug delivery. Int. J. Pharm. 336 (2007) 183-190
16. D'Emanuele A., Jevprasesphant R., Penny J., and Attwood D. The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability. J. Control. Release 95 (2004) 447-453
17. Majoros I.J., Myc A., Thomas T.P., Mehta C.B., and Baker Jr. J.R. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Biomacromolecules 7 (2006) 572-579
18. Thomas T.P., Majoros I.J., Kotlyar A., Kukowska-Latallo J.F., Bielinska A., Myc A., and Baker Jr. J.R. Targeting and inhibition of cell growth by an engineered dendritic nanodevice. J. Med. Chem. 48 (2005) 3729-3735
19. Svenson S., and Tomalia D.A. Dendrimers in biomedical applications - reflections on the field. Adv. Drug Deliv. Rev. 57 (2005) 2106-2129
20. Boas U., and Heegaard P.M.H. Dendrimers in drug research. Chem. Soc. Rev. 33 (2004) 43-63
21. Gupta U., Agashe H.B., Asthana A., and Jain N.K. Dendrimers: novel polymeric nanoarchitectures for solubility enhancement. Biomacromolecules 7 (2006) 649-658
22. Cheng Y.Y., Wang J.R., Rao T.L., He X.X., and Xu T.W. Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery. Front. Biosci. 13 (2008) 1447-1471
23. Cheng Y.Y., Gao Y., Rao T.L., Li Y.W., and Xu T.W. Dendrimer-based prodrugs: design, synthesis, screening and biological evaluation. Comb. Chem. High Throughput Screen. 10 (2007) 336-349
24. D'Emanuele A., and Attwood D. Dendrimer-drug interactions. Adv. Drug Deliv. Rev. 57 (2005) 2147-2162
25. Bhadra D., Yadav A.K., Bhadra S., and Jain N.K. Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. Int. J. Pharm. 295 (2005) 221-233
26. Majoros I.J., Thomas T.P., Mehta C.B., and Baker Jr. J.R. Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. J. Med. Chem. 48 (2005) 5892-5899
27. Kukowska-Latallo J.F., Candido K.A., Cao Z.Y., Nigavekar S.S., Majoros I.J., Thomas T.P., Balogh L.P., Khan M.K., and Baker Jr. J.R. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 65 (2005) 5317-5324
28. Patri A.K., Kukowska-Latallo J.F., and Baker Jr. J.R. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv. Drug Deliv. Rev. 57 (2005) 2203-2214
29. Choi Y., Thomas T., Kotlyar A., Islam M.T., and Baker Jr. J.R. Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting. Chem. Biol. 12 (2005) 35-43
30. Patri A.K., Myc A., Beals J., Thomas T.P., Bander N.H., and Baker J.R. Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy. Bioconjug. Chem. 15 (2004) 1174-1181
31. Shukla R., Thomas T.P., Peters J.L., Desai A.M., Kukowska-Latallo J., Patri A.K., Kotlyar A., and Baker Jr. J.R. HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb. Bioconjug. Chem. 17 (2006) 1109-1115
32. Yang W., Barth R.F., Wu G., Bandyopadhyaya A.K., Thirumamagal B.T., Tjarks W., Binns P.J., Riley K., Patel H., Coderre J.A., Ciesielski M.J., and Fenstermaker R.A. Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas. Appl. Radiat. Isot. 61 (2004) 981-985
33. Barth R.F., Wu G., Yang W.L., Binns P.J., Riley K.J., Patel H., Coderre J.A., Tjarks W., Bandyopadhyaya A.K., Thirumamagal B.T., Ciesielski M.J., and Fenstermaker R.A. Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent. Appl. Radiat. Isot. 61 (2004) 899-903
34. Russell-Jones G., McTavish K., and McEwan J. Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumors. J. Inorg. Biochem. 98 (2004) 1625-1633
35. Marek M., Kaiser K., and Gruber H.J. Biotin-pyrene conjugates with poly(ethylene glycol) spacers are convenient fluorescent probes for avidin and streptavidin. Bioconjug. Chem. 8 (1997) 560-566
36. Cannizzaro S.M. A novel biotinylated degradable polymer for cell-interactive applications. Biotechnol. Bioeng. 58 (1998) 529-535
37. Na K. Self-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system. Eur. J. Pharm. Sci. 18 (2003) 165-173
38. Mishra P.R., and Jain N.K. Biotinylated methotrexate loaded erythrocytes for enhanced liver uptake. 'A study on the rat'. Int. J. Pharm. 231 (2002) 145-153
39. Dufes C., Uchegbu I.F., and Schatzlein A.G. Dendrimers in gene delivery. Adv. Drug Deliv. Rev. 57 (2005) 2177-2202
40. Kansara V., Luo S.H., Balasubrahmanyam B., Pal D., and Mitra A.K. Biotin uptake and cellular translocation in human derived retinoblastoma cell line (Y-79): a role of hSMVT system. Int. J. Pharm. 312 (2006) 43-52
41. Luo S., Kansara V., Zhu X., Mandava N.K., Pal D., and Mitra A.K. Functional characterization of sodium-dependent multivitamin transporter in MDCK-MDR 1 cells and its utilization as a target for drug delivery. Mol. Pharm. 3 (2006) 329-339
42. Pacheco-Alvarez D., Solorzano-Vargas R.S., Gonzalez-Noriega A., Michalak C., Zempleni J., and Leon-Del-Rio A. Biotin availability regulates expression of the sodium-dependent multivitamin transporter and the rate of biotin uptake in HepG2 cells. Mol. Genet. Metab. 85 (2005) 301-307
43. Khandare J.J., Jayant S., Singh A., Chandna P., Wang Y., Vorsa N., and Minko T. Dendrimer versus linear conjugate: influence of polymeric architecture on the delivery and anticancer effect of paclitaxel. Bioconjug. Chem. 17 (2006) 1464-1472